𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data

✍ Scribed by Craig H Mallinckrodt; Todd M Sanger; Sanjay Dubé; David J DeBrota; Geert Molenberghs; Raymond J Carroll; William Z Potter; Gary D Tollefson

Book ID
119409073
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
60 KB
Volume
53
Category
Article
ISSN
0006-3223

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessing treatment–time interaction in
Assessing treatment–time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials
✍ F. Boutitie; F. Gueyffier; S. J. Pocock; J. P. Boissel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 3 views

Exploration of the variation of treatment effect over time in randomized clinical trials with low event rates is limited by lack of power. A meta-analysis on individual patient data from such trials can partly solve the problem, but brings other computational difficulties. Using an example in hypert

Assessing Treatment Effect Heterogeneity
Assessing Treatment Effect Heterogeneity in Clinical Trials with Blocked Binary Outcomes
✍ Jeffrey M. Albert; Gary L. Gadbury; Edward J. Mascha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views

This paper addresses treatment effect heterogeneity (also referred to, more compactly, as 'treatment heterogeneity') in the context of a controlled clinical trial with binary endpoints. Treatment heterogeneity, variation in the true (causal) individual treatment effects, is explored using the concep